Defense Health Program Department of Defense Peer Reviewed Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2021 (FY21) - July 29, 2021 deadlines
Behavioral Health Science Award - Letter of Intent due July 29, 2021
Independent investigator with a faculty-level appointment (or equivalent).
- Letter of Intent is required. An invitation to submit a full application is not required.
- Supports research that span the spectrum of behavioral health science including prevention, survivorship, quality of life, and psychosocial research related to cancer.
- Must address at least one of the FY21 PRCRP Topic Areas.
- Must address at least one of the FY21 PRCRP Military Health Focus Areas.
- Preliminary data required.
- Pilot clinical trials are allowed.
- The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
- Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
- The maximum period of performance is 4 years.
Career Development Award – Fellow Option – Letter of Intent due July 29, 2021
Principal Investigator (PI): Independent investigators at or above the level of Assistant Professor or Instructor (or equivalent) and within 7 years after completion of their terminal degree (excluding time spent in residency or on family medical leave) by the time of the application submission deadline.
Career Guide: Investigators at or above the level of Associate Professor (or equivalent); must have a proven publication and funding record in cancer research
- Letter of Intent is required. An invitation to submit a full application is not required.
- Supports independent, early-career investigators to conduct impactful research with the mentorship of an experienced cancer researcher.
- Must address at least one of the FY21 PRCRP Topic Areas.
- Must address at least one of the FY21 PRCRP Military Health Focus Areas.
- Preliminary data are not required.
- Clinical trials are not allowed.
- The maximum allowable funding for the entire period of performance is $400,000 for direct costs.
- Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
- The maximum period of performance is 3 years.
Translational Team Science Award – Letter of Intent due July 29, 2021
At least two, and a maximum of three, PIs must partner in one overarching correlative or translational research study.
- Letter of Intent is required. An invitation to submit a full application is not required.
- Emphasizes multi-PI, multidisciplinary collaborations.
- Supports translational studies associated with an ongoing or completed clinical trial that can lead to a future clinical trial or clinical application in cancer research.
- Not intended to support high throughput screenings, sequencing, etc.
- Must address at least one of the FY21 PRCRP Topic Areas.
- Must address at least one of the FY21 PRCRP Military Health Focus Areas.
- Preliminary data are required.
- Clinical Trials are allowed.
- The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
- Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
- The maximum period of performance is 4 years.
- At least one of the PIs is encouraged to be a military or US Department of Veterans Affairs investigator.